qPCR Instruments Market Set to Reach USD 1.8 Billion by 2033 at a 3.5% of CAGR, Driven by Advances in Genetic Research and Diagnostics

The global qPCR Instruments Market is poised for steady growth, with sales reaching US$ 1.2 billion in 2022, according to a newly-released analysis report by Future Market Insights. The market is projected to expand at a compound annual growth rate (CAGR) of 3.5% from 2023 to 2033, ultimately achieving a valuation of US$ 1.8 billion.

The growth of the qPCR (quantitative Polymerase Chain Reaction) instruments market is primarily driven by advancements in genetic research, increased demand for diagnostic testing, and the growing focus on personalized medicine.

Key Market Drivers:

• Advancements in Genetic Research: Ongoing developments in molecular biology and genetics are significantly increasing the demand for qPCR instruments. These tools are essential for various applications, including gene expression analysis, pathogen detection, and genetic variation studies.
• Rising Demand for Diagnostic Testing: The global emphasis on early disease detection and monitoring is propelling the demand for qPCR instruments in clinical laboratories and healthcare facilities. Their ability to provide rapid and accurate results makes them invaluable in diagnostics.
• GeneXpert Instrument Growth: The GeneXpert instrument segment is expected to generate the highest revenue, projected to account for a CAGR of 3.5% from 2023 to 2033. Its widespread adoption for molecular testing, particularly in infectious diseases, is a key factor in this growth.

Regional Insights: North America is anticipated to hold a significant share of the qPCR instruments market, driven by advanced healthcare infrastructure, strong research capabilities, and a high prevalence of chronic diseases. Europe is also expected to contribute notably to market growth, while the Asia-Pacific region is projected to see the fastest expansion due to increasing investments in healthcare and rising awareness of molecular diagnostics.

Market Outlook: As the qPCR instruments market continues to evolve with technological advancements and growing applications in diagnostics and research, it is well-positioned for consistent growth over the next decade. The combination of increasing healthcare needs and the importance of genetic research will further drive market expansion through 2033.

What was the Impact of Covid-19 on the qPCR Instruments Market?

Coronavirus has upgraded the number of diagnostic devices that can be utilized. In affluent economies, further developed PCR strategies, like dPCR, are utilized since they can help lower misleading positive rates. The improvement of viable qPCR instruments could decrease the danger of gadget replacement and lift market development. The expanded spotlight on diagnostics due to COVID-19’s development is expected to drive interest in qPCR instruments later in the years.

Competitive Analysis

The key players operating in the market include Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Abbott, Qiagen, Azure Biosystems Inc., and Quantabio.

• In November 2020, Streck launched its Zulu RT, qPCR instrument. This can be utilized to perform four trials simultaneously and autonomously. The more prominent adaptability of this instrument was supposed to assist capture a share of the market.

Similarly, recent developments related to companies offering QPCR Instruments Market have been tracked by the team at Future Market Insights, which are available in the full report.

A Full Report Overview

Market Segments Covered in qPCR Instruments Industry Analysis

By Instrument Type:

• 7500
• QuantStudioDx Real-Time PCR System
• QuantStudio 5 Real-Time PCR System
• ViiA 7 Dx
• StepOne/ StepOne Plus
• LightCycler 2.0/ 96/ 480/ 1536
• Cobas 4800
• SmartCycler
• GeneXpert
• Rotor-Gene Q 5Plex HRM System
• Others

By Region:

• North America
  • USA
  • Canada
  • Rest of North America
• Europe
  • Germany
  • Spain
  • UK
  • Italy
  • France
  • Netherlands
  • Belgium
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• MEA
  • South Africa
  • Saudi Arabia
  • Nigeria
  • Rest of MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube